Literature DB >> 14561150

Stem cell factor: a hemopoietic cytokine with important targets in asthma.

S H P Oliveira1, N W Lukacs.   

Abstract

We review evidence that Stem Cell Factor (SCF) plays an important role in the pathophysiology of asthma. SCF is produced by a wide variety of cells present in asthmatic lung, including mast cells and eosinophils. Its receptor, c-kit, is broadly expressed on mature mast cells and eosinophils. SCF promotes recruitment of mast cell progenitors into tissues, as well as their local maturation and activation. It also promotes eosinophil survival, maturation and functional activation. SCF enhances IgE-dependent release of mediators from mast cells, including histamine, leukotrienes, cytokines (TNF-alpha, IL-5, GM-CSF) and chemokines (RANTES/CCL5, MCP-1/CCL2, TARC/CCL17 e MDC/CCL22); it is required for IL-4 production in mast cells. SCF, acting in concert with IgE, also upregulates the expression and function of CC chemokine receptors in mast cells. Structural and resident airway cells express increased levels of SCF in the bronchus of asthmatic patients. In a murine model of asthma, allergen exposure increased production of SCF by epithelial cells and alveolar macrophages, which was transient and paralleled by histamine release. SCF induced long-lived airway hyperreactivity, which was prevented by local neutralization of SCF, as well as by inhibitors of the production or activity of cysteinyl-leukotrienes. Together, these observations suggest that SCF has an important role in asthma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561150     DOI: 10.2174/1568010033483990

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  19 in total

1.  Asthma: new developments in cytokine regulation.

Authors:  R J Boyton; D M Altmann
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

3.  Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung.

Authors:  Antoon Dijkstra; Dirkje S Postma; Jacobien A Noordhoek; Monique E Lodewijk; Henk F Kauffman; Nick H T ten Hacken; Wim Timens
Journal:  Virchows Arch       Date:  2009-03-03       Impact factor: 4.064

Review 4.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 5.  Signaling of c-kit in dendritic cells influences adaptive immunity.

Authors:  Prabir Ray; Nandini Krishnamoorthy; Timothy B Oriss; Anuradha Ray
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 6.  Structural and functional properties of platelet-derived growth factor and stem cell factor receptors.

Authors:  Carl-Henrik Heldin; Johan Lennartsson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

7.  Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Authors:  Vladislav A Dolgachev; Matthew R Ullenbruch; Nicholas W Lukacs; Sem H Phan
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

8.  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.

Authors:  Andrew Rasky; David M Habiel; Susan Morris; Matthew Schaller; Bethany B Moore; Sem Phan; Steven L Kunkel; Martin Phillips; Cory Hogaboam; Nicholas W Lukacs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

Review 9.  ADAM8: a new therapeutic target for asthma.

Authors:  Martin D Knolle; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2009-05       Impact factor: 6.902

Review 10.  New models for analyzing mast cell functions in vivo.

Authors:  Laurent L Reber; Thomas Marichal; Stephen J Galli
Journal:  Trends Immunol       Date:  2012-11-02       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.